Combination of Visual and Metabolic Markers in Assessment of Probability of Presence and Severity of Atherosclerosis of Coronary Arteries

被引:0
|
作者
Metelskaya, V. A. [1 ]
Gavrilova, N. E. [1 ]
Gumanova, N. G. [1 ]
Litinskaya, O. A. [1 ]
Yarovaya, E. B. [1 ]
Boytsov, S. A. [1 ]
机构
[1] Natl Res Ctr Prevent Med, Moscow, Russia
关键词
coronary atherosclerosis; risk modeling; lipoproteins; imaging biomarkers; metabolic biomarkers; CARDIOVASCULAR-DISEASE; RISK; BIOMARKERS; ADULTS;
D O I
10.18565/cardio.2016.7.47-53
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: to assess possibilities of the use of biochemical markers combined with data of methods of imaging of arterial atherosclerotic lesions for evaluation of risk of presence and severity of coronary atherosclerosis. Materials and methods. We enrolled into this study patients (n=205, 136 men, 69 women, age 33-85 years, 94% on statin therapy) who underwent coronary angiography and carotid artery ultrasound dopplerography. Examination included determination of parameters of lipid profile and carbohydrate metabolism, markers of inflammation and metabolism of visceral adipose tissue. The severity of carotid artery atherosclerosis was estimated using mean common carotid artery intima-media thickness and atherosclerotic plaques presence. Severity of coronary atherosclerosis was evaluated using Gensini score. Results. We found association between a number of biomarkers and severity of coronary artery involvement. Presence of coronary atherosclerosis (Gensini score >0) was associated with male sex, carotid artery stenosis >45%, and adiponectin level <8.0 pg/ml. Overt coronary atherosclerosis (Gensini score >= 35) significantly correlated with intima-media thickness >= 0.9 mm, C-reactive protein level >3.0 mg/l and adiponectin level <8.0 pg/ml.
引用
下载
收藏
页码:47 / 53
页数:7
相关论文
共 50 条
  • [31] Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans
    Yoo, JH
    Park, JE
    Hong, KP
    Lee, SH
    Kim, DK
    Lee, WR
    Park, SC
    THROMBOSIS RESEARCH, 1999, 94 (01) : 45 - 52
  • [32] Influences of new risk markers on the severity of coronary atherosclerosis in patients with different risk profiles
    Guler, S.
    Yavuz, O.
    Yavuz, M. T.
    Yazici, M.
    Ozhan, H.
    Coskun, A.
    Albayrak, S.
    FEBS JOURNAL, 2006, 273 : 219 - 219
  • [33] ASSESSMENT OF CORONARY ATHEROSCLEROSIS SEVERITY IN MEN WITH CORONARY HEART DISEASE DEPENDING ON BONE MINERAL DENSITY
    Raskina, T.
    Voronkina, A.
    Letaeva, M.
    Kokov, A.
    Elena, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1192 - 1193
  • [34] Visual Scale as a Non-Invasive Method for Evaluation of Risk and Severity of Coronary Atherosclerosis
    Zhatkina, M. V.
    Gavrilova, N. E.
    Metel'skaya, V. A.
    Yarovaya, E. B.
    Rudenko, B. A.
    Drapkina, O. M.
    KARDIOLOGIYA, 2021, 61 (04) : 46 - 51
  • [35] Relation of ABO blood groups to the severity of coronary atherosclerosis: An Gensini score assessment
    Gong, Ping
    Luo, Song-Hui
    Li, Xiao-Lin
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Xu, Rui-Xia
    Li, Sha
    Dong, Qian
    Liu, Geng
    Chen, Juan
    Zeng, Rui-Xiang
    Li, Jian-Jun
    ATHEROSCLEROSIS, 2014, 237 (02) : 748 - 753
  • [36] Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis
    Broedl, U. C.
    Lehrke, M.
    Becker, A.
    Greif, M.
    Stark, R.
    Laubender, R. P.
    von Ziegler, F.
    Lebherz, C.
    Tittus, J.
    Reiser, M.
    Becker, C.
    Goeke, B.
    Leber, A. W.
    Parhofer, K. G.
    DIABETOLOGIA, 2009, 52 : S514 - S514
  • [37] Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis
    Coutinho, Thais de A.
    Turner, Stephen T.
    Peyser, Patricia A.
    Bielak, Lawrence F.
    Sheedy, Patrick F., II
    Kullo, Iftikhar J.
    AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (01) : 83 - 89
  • [38] Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis
    Lehrke, Michael
    Becker, Alexander
    Greif, Martin
    Stark, Renee
    Laubender, Ruediger P.
    von Ziegler, Franz
    Lebherz, Corinna
    Tittus, Janine
    Reiser, Maximilian
    Becker, Christoph
    Goeke, Burkhard
    Leber, Alexander W.
    Parhofer, Klaus G.
    Broedl, Uli C.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (02) : 339 - 344
  • [39] Lipoprotein Subfractions as Markers for Predicting the Presence and Severity of Coronary Artery Disease in Patients Undergoing Coronary Angiography
    Li, Tingting
    Zhang, Yingyi
    Xu, Jinghan
    Wang, Le
    Zhang, Fomin
    Cong, Hongliang
    ANGIOLOGY, 2023, 74 (05) : 435 - 442
  • [40] Assessment of Subclinical Manifestations of Atherosclerosis of Coronary and Peripheral Arteries and Bone Strength Parameters in Women
    Skripnikova, Irina A.
    Kolchina, Maria A.
    Kosmatova, Olga, V
    Myagkova, Margarita A.
    Novikov, Valery E.
    Isaykina, Olesya Yu
    Drapkina, Oxana M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (06) : 868 - 875